XML 17 R5.htm IDEA: XBRL DOCUMENT v3.19.2
Consolidated Statement of Stockholders' Equity (unaudited) - USD ($)
Total
Common stock issued for cash at $5.25 per share
Common Stock
Common Stock
Common stock issued for cash at $5.25 per share
Additional Paid-In Capital
Additional Paid-In Capital
Common stock issued for cash at $5.25 per share
Accumulated Other Comprehensive Income (loss)
Accumulated Deficit
Non-controlling Interest
Beginning Balance, Amount at Sep. 30, 2017 $ 80,867,162   $ 167,155   $ 514,037,301   $ 33,232 $ (432,815,338) $ (555,188)
Beginning Balance, Shares at Sep. 30, 2017     74,785,426            
Stock-based compensation 5,818,119       5,818,119        
Exercise of stock options, Amount 1,032,058   $ 283   1,031,775        
Exercise of stock options, Shares     283,627            
Exercise of warrants, Amount 1,237,430   $ 289   1,237,141        
Exercise of warrants, Shares     288,473            
Common stock- Restricted Stock Units vesting, Amount (54,668)   $ 997   (55,665)        
Common stock- Restricted Stock Units vesting, Shares     997,125            
Common stock issued   $ 56,585,035   $ 11,500   $ 56,573,535      
Common stock issued, Shares       11,500,000          
Foreign currency translation adjustments (36,570)           (36,570)    
Net income (loss) (43,689,207)             (43,689,207)  
Ending Balance, Amount at Jun. 30, 2018 101,759,359   $ 180,224   578,642,206   (3,338) (476,504,545) (555,188)
Ending Balance, Shares at Jun. 30, 2018     87,854,651            
Beginning Balance, Amount at Mar. 31, 2018 113,715,081   $ 179,940   574,963,592   25,265 (460,898,528) (555,188)
Beginning Balance, Shares at Mar. 31, 2018     87,570,398            
Stock-based compensation 2,268,765       2,268,765        
Exercise of stock options, Amount 838,933   $ 204   838,729        
Exercise of stock options, Shares     204,253            
Exercise of warrants, Amount 571,200   $ 80   571,120        
Exercise of warrants, Shares     80,000            
Foreign currency translation adjustments (28,603)           (28,603)    
Net income (loss) (15,606,017)             (15,606,017)  
Ending Balance, Amount at Jun. 30, 2018 101,759,359   $ 180,224   578,642,206   (3,338) (476,504,545) (555,188)
Ending Balance, Shares at Jun. 30, 2018     87,854,651            
Beginning Balance, Amount at Sep. 30, 2018 95,241,001   $ 180,875   582,902,694   (21,564) (487,265,816) (555,188)
Beginning Balance, Shares at Sep. 30, 2018     88,505,302            
Stock-based compensation 7,276,875       7,276,875        
Exercise of stock options, Amount $ 6,442,005   $ 1,244   6,440,761        
Exercise of stock options, Shares 1,244,161   1,244,161            
Common stock- Restricted Stock Units vesting, Amount     $ 2,197   (2,197)        
Common stock- Restricted Stock Units vesting, Shares     2,197,305            
Common stock issued $ 60,521,729   $ 3,261   60,518,468        
Common stock issued, Shares     3,260,869            
Foreign currency translation adjustments (81,514)           (81,514)    
Net income (loss) 56,269,944             56,269,944  
Ending Balance, Amount at Jun. 30, 2019 225,670,040   $ 187,577   657,136,601   (103,078) (430,995,872) (555,188)
Ending Balance, Shares at Jun. 30, 2019     95,207,637            
Beginning Balance, Amount at Mar. 31, 2019 200,640,237   $ 187,035   652,411,876   (71,906) (451,331,580) (555,188)
Beginning Balance, Shares at Mar. 31, 2019     94,665,718            
Stock-based compensation 1,957,993       1,957,993        
Exercise of stock options, Amount 2,767,274   $ 542   2,766,732        
Exercise of stock options, Shares     541,919            
Foreign currency translation adjustments (31,172)           (31,172)    
Net income (loss) 20,335,708             20,335,708  
Ending Balance, Amount at Jun. 30, 2019 $ 225,670,040   $ 187,577   $ 657,136,601   $ (103,078) $ (430,995,872) $ (555,188)
Ending Balance, Shares at Jun. 30, 2019     95,207,637